Antifúngicos y sol...
Voriconazole Use Tied To Higher Risk Of Cutaneous Squamous Cell Carcinoma In Patients With Lung Transplant Or Hematopoietic Cell Transplant, Review Indicates.
Dermatology Advisor (10/26) reported researchers found in a "systematic literature review and meta-analysis" that "use of voriconazole is associated with an increased risk for cutaneous squamous cell carcinoma (SCC) in patients with lung transplant (LT) or hematopoietic cell transplant (HCT)." The findings were published in the Journal of the American Academy of Dermatology
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home